Rajgopal Govindarajan, Ph.D. - Publications

Affiliations: 
2005 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Molecular Biology, Cell Biology, Oncology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Nayak D, Weadick B, Persaud AK, Raj R, Shakya R, Li J, Campbell MJ, Govindarajan R. EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer. Iscience. 25: 104193. PMID 35479410 DOI: 10.1016/j.isci.2022.104193  0.306
2020 Weadick B, Nayak D, Persaud AK, Hung SW, Raj R, Campbell MJ, Chen W, Li J, Williams TM, Govindarajan R. EMT-induced gemcitabine resistance in pancreatic cancer involves the functional loss of equilibrative nucleoside transporter 1. Molecular Cancer Therapeutics. PMID 33298588 DOI: 10.1158/1535-7163.MCT-20-0316  0.363
2019 Nair S, Strohecker AM, Persaud AK, Bissa B, Muruganandan S, McElroy C, Pathak R, Williams M, Raj R, Kaddoumi A, Sparreboom A, Beedle AM, Govindarajan R. Adult stem cell deficits drive Slc29a3 disorders in mice. Nature Communications. 10: 2943. PMID 31270333 DOI: 10.1038/S41467-019-10925-3  0.542
2018 Rahman MF, Raj R, Govindarajan R. Identification of structural and molecular features involved in the transport of 3'-deoxy-nucleoside analogs by human equilibrative nucleoside transporter 3. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 29530865 DOI: 10.1124/Dmd.117.079400  0.348
2017 Mody HR, Hung SW, Naidu K, Lee H, Gilbert CA, Hoang TT, Pathak RK, Manoharan R, Muruganandan S, Govindarajan R. SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Oncotarget. 8: 67966-67979. PMID 28978088 DOI: 10.18632/Oncotarget.19067  0.586
2017 Mody HR, Hung SW, Naidu K, Lee H, Gilbert CA, Hoang TT, Pathak RK, Manoharan R, Muruganandan S, Govindarajan R. SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Oncotarget. PMID 28723647 DOI: 10.18632/oncotarget.19067  0.319
2017 Mody H, Hung SW, Pathak R, Griffin J, Cruz-Monserrate Z, Govindarajan R. miR-202 Diminishes TGFbeta Receptors and Attenuates TGFbeta1-induced EMT in Pancreatic Cancer. Molecular Cancer Research : McR. PMID 28373289 DOI: 10.1158/1541-7786.Mcr-16-0327  0.547
2017 Mody HR, Govindarajan R. A non-coding RNA axis guides TGF-β-induced gemcitabine chemoresistance Translational Cancer Research. 6. DOI: 10.21037/17142  0.317
2017 Mody HR, Govindarajan R. Abstract 3421: Pharmacological inhibition of histone methylation attenuates TGFβ induced EMT characteristics in pancreatic cancer Cancer Research. 77: 3421-3421. DOI: 10.1158/1538-7445.Am2017-3421  0.335
2016 Muruganandan S, Govindarajan R, McMullen NM, Sinal CJ. Chemokine-Like Receptor 1 (CMKLR1) is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation. Stem Cells (Dayton, Ohio). PMID 27733019 DOI: 10.1002/Stem.2520  0.301
2016 Mody H, Hung SW, Al-Saggar M, Griffin J, Govindarajan R. Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGF-beta1-induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p. Molecular Cancer Research : McR. PMID 27624777 DOI: 10.1158/1541-7786.Mcr-16-0083  0.316
2016 Bissa B, Beedle AM, Govindarajan R. Lysosomal Solute Carrier Transporters Gain Momentum in Research. Clinical Pharmacology and Therapeutics. PMID 27530302 DOI: 10.1002/Cpt.450  0.333
2016 Govindarajan R, Modi H. Abstract 1913: Inhibition of S-Adenosylmethionine-dependent methyltransferase resists TGF-β1-induced EMT of pancreatic cancer via microRNA alterations Cancer Research. 76: 1913-1913. DOI: 10.1158/1538-7445.Am2016-1913  0.359
2015 Hung SW, Marrache S, Cummins S, Bhutia YD, Mody H, Hooks SB, Dhar S, Govindarajan R. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach. Cancer Letters. 359: 233-40. PMID 25600708 DOI: 10.1016/J.Canlet.2015.01.017  0.603
2013 Hung SW, Mody H, Marrache S, Bhutia YD, Davis F, Cho JH, Zastre J, Dhar S, Chu CK, Govindarajan R. Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studies. Plos One. 8: e71196. PMID 23940717 DOI: 10.1371/Journal.Pone.0071196  0.593
2011 Bhutia YD, Hung SW, Patel B, Lovin D, Govindarajan R. CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells. Cancer Research. 71: 1825-35. PMID 21343396 DOI: 10.1158/0008-5472.Can-10-2736  0.468
2010 Govindarajan R, Chakraborty S, Johnson KE, Falk MM, Wheelock MJ, Johnson KR, Mehta PP. Assembly of connexin43 into gap junctions is regulated differentially by E-cadherin and N-cadherin in rat liver epithelial cells. Molecular Biology of the Cell. 21: 4089-107. PMID 20881055 DOI: 10.1091/Mbc.E10-05-0403  0.605
2002 Govindarajan R, Zhao S, Song XH, Guo RJ, Wheelock M, Johnson KR, Mehta PP. Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by alpha-catenin. The Journal of Biological Chemistry. 277: 50087-97. PMID 12205082 DOI: 10.1074/Jbc.M202652200  0.562
Show low-probability matches.